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ABSTRACT
Objective: To assess the effect of the antibiotic Gentamicin in an experimental model in 
the presence of Diabetes Mellitus through renal function and oxidative profile. Method: 
Adult male Wistar rats were distributed into groups: Citrate; Gentamicin (Genta), 
(intraperitoneal, i.p. gentamicin, 100 mg/kg of body weight, once a day,5 days); DM 
(60 mg/kg of STZ (Streptozotocin), single dose, intravenously, i.v., diluted in citrate buffer); 
and DM+Genta. Physiological parameters, renal function (creatinine clearance), oxidative 
damage (peroxides and thiobarbituric acid reactive substances – urinary TBARS) and 
renal hemodynamics were evaluated. Results: The Diabetes Mellitus group presented 
chronic hyperglycemia associated with loss of body weight, polyphagia, polydipsia 
and polyuria, in addition to reduced renal function and with an increase in oxidative 
metabolite excretion. Administration of gentamicin induced a reduction in renal blood 
flow and increased renal vascular resistance in healthy rats. The association of Diabetes 
Mellitus with gentamicin resulted in an additional reduction in renal function and 
elevation of oxidative metabolites, with increased renal vascular resistance. Conclusion: 
The existence of Diabetes Mellitus resulted in an elevation of gentamicin nephrotoxicity, 
thus confirming the risk factor for drug nephrotoxicity.
DESCRIPTORS
Acute Kidney Injury; Diabetes Mellitus; Gentamicins; Oxidative Stress.
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INTRODUCTION
Acute kidney injury (AKI) consists of an abrupt reduc-
tion of renal function (RF), clinically signaled by the ele-
vation of serum creatinine to levels greater than or equal to 
0.3 mg/dL in 48 hours, or a 1.5-fold increase in this marker 
over a 7-dayperiod(1). The main causes of AKI are drug neph-
rotoxicity or renal ischemic events. The high mortality of 
patients affected by this syndrome, between 15% to 60%(2), 
justifies scientific investments to elucidate the mechanisms 
that precipitate it, as well as a proposition of therapeutic 
interventions that can mitigate its evolution.
AKI is less frequent in the general community than 
in hospitalized patients, and its prevalence is significant 
in Intensive Care Units (ICUs), affecting 20% to 40% of 
the patients hospitalized in these units(2). Gentamicin is an 
aminoglycoside antibiotic, widely used in the fight against 
gram-negative bacterial infections and has nephrotoxicity 
as one of its main side effects. This is because its excretion 
predominantly occurs by glomerular filtration. The patho-
physiology of gentamicin nephrotoxicity is characterized by 
damage to tubular and glomerular renal cells(3-4),associated 
with oxidative stress, generation of reactive oxygen species 
(ROS) and reduced antioxidant enzymes in the kidney(5). 
Chronic diseases are described as risk factors for the 
occurrence of AKI in critically ill patients or those under-
going diagnostic procedures involving the administration of 
nephrotoxic drugs. Among this group of morbidities, we can 
highlight Diabetes Mellitus (DM), being the subject of 
interest in this study. Little is known about the cellular and 
functional principles that act as facilitators in the occurrence 
of nephrotoxicity of drugs in the occasion of comorbidities 
such as DM(6).
The absence of data on the mechanisms that predis-
pose individuals with DM to the development of AKI due 
to nephrotoxicity of drugs, especially gentamicin, supports 
implementing investigations aimed at elucidating the co-in-
terference of these factors in the patient’s clinical evolution 
and that seek to clarify this knowledge gap in the area of 
intensive care, in which the entire health team is involved. 
The aim of this study was to evaluate the effect of gentamicin 
in diabetic rats through an evaluation of renal function and 
the oxidative profile.
METHOD
This was a quantitative and experimental study developed 
with rats. The rats from the various groups were kept with 
free access to water and food and remained under adequate 
thermal conditions with alternating cycles of day and night. 
All procedures performed in this study are in accordance 
with the Ethical Principles of Animal Experimentation 
adopted by the Brazilian College of Animal Experimentation 
(COBEA – Colégio Brasileiro de Experimentação Animal) and 
were approved by the Commission of Ethics in Animal 
Experimentation (Comissão de Ética em Experimentação 
Animal – CEEA 155/15).
Animals: Twenty-one adult male Wistar rats weigh-
ing 250-300 grams distributed into the following 4 
groups were used: Citrate (Control): administration of 
citrate buffer (0.01 M pH 4.2, i.v. in the caudal vein); 
Gentamicin: animals who received gentamicin (gentami-
cin, 100 mg/kg of body weight, once a day, intraperitone-
aly, i.p., for 5 days); DM: induction of DM by administra-
tion of streptozotocin (STZ) (60 mg/kg, diluted in 0.01 
M citrate buffer pH 4.2, i.v)(7-8); and Gentamicin+DM: 
animals with DM who received gentamicin after 4 weeks 
of DM induction. 
The animals submitted to the DM model had their 
glycemic blood levels evaluated by blood glucose test 
48 hours after induction using Advantage reagent strips 
(Advantage – Roche®, Brazil). Animals that presented 
glycemic blood levels above 250 mg/dl in this period were 
considered diabetic. All diabetic animals had their body 
weight and blood glucose monitored for 4 weeks (28 days) 
once a week.
Obtaining the biological material: At the end of the pro-
tocol, the animals were placed in individual metabolic cages 
for the collection of 24-hour urine to evaluate renal function 
and oxidative metabolites. After this period, the animals 
were anesthetized with thiopental sodium (40-50 mg/kg, 
i.p.) for collection of terminal blood through puncturing the 
abdominal aorta and subsequent evaluation of renal function. 
Finally, euthanasia of the animal was performed at the end 
of the experiment according to the ethical standards for the 
handling of animals in research.
Renal function: Renal function was assessed by creati-
nine clearance. The Jaffé colorimetric method was used to 
determine serum and urinary creatinine values. Creatinine 
clearance was calculated by the formula(9): creatinine 
clearance = urinary creatinine x 24-hour urinary flow / 
serum creatinine. 
Oxidative metabolites: Oxidative metabolites were eval-
uated by measuring urinary peroxides and thiobarbituric 
acid reactive substances (TBARS).The evaluation of uri-
nary peroxides was performed by the FOX-2 method, 
in which the use of an orange iron-xylenol oxidizes the 
Fe2+ ion producing a complex of purplish-blue coloration 
(α= 4.3 x 104 M-1 cm-1)(10-11). An evaluation of urinary 
TBARS allows identification of end products of the lipid 
peroxidation cascade that react in the presence of thiobar-
bituric acid in organic fluids (α= 1.56 x 105 M-1 cm-1)(12-13).
Renal Hemodynamics: Renal hemodynamics were 
assessed by measuring renal blood flow (RBF), mean arte-
rial pressure and renal vascular resistance. For renal blood 
flow, the left renal artery was isolated and involved by ultra-
sonic probes to measure the blood flow of the vessel. Mean 
arterial pressure (MAP) was determined by carotid artery 
catheterization, while renal vascular resistance (RVR) was 
calculated according to the following formula: RVR = 
MAP / RBF(14).
Statistical analysis: The results were presented as mean 
± standard deviation. The statistical analysis of the results 
was performed by analysis of variance (ANOVA), followed 
by Newman-Keuls multiple comparisons in the statistical 
program Graph-Pad Prism version-3 for Windows®. The 
considered significance level was 5%.
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RESULTS 
Physiological Parameters
The physiological parameters of the groups were 
demonstrated by food and water intake, animal body 
weight, kidney weight/animal weight ratio and glycemia, as 
shown in Table 1. It was possible to observe an increase in 
the weight of the Citrate group (control) when compared 
to the groups Genta, DM and DM+Genta. All treated 
groups presented a renal hypertrophy coefficient, repre-
sented by an increase in the kidney weight/animal weight 
ratio, with the highest indices being observed for groups 
of diabetic animals. Other characteristics that confirm 
the standardization of the DM model are polyphagia and 
polydipsia, indicated by the increase in food and water 
intake by diabetic rats, and hyperglycemia in the DM and 
DM+Genta groups.
Table 1 – Physiological parameters of the Citrate, Genta, DM and DM+Genta groups – São Paulo, SP, Brazil, 2017.
Groups (n) Water intake 24 h (ml)
Food intake
24 h (g) Animal weight (g) Kidney weight (g)
Kidney weight/
Animal weight (%) Glycemia (mg/dL)
Citrate (5) 30.0 ± 7.0 23.0 ± 3.5 392 ± 48 1.41 ± 0.20 0.36 ± 0.03 110±3.0
Genta (5) 33.0 ± 5.7 15.2 ± 4.9 320 ± 27a 1.14 ± 0.22 0.39 ± 0.09a 107±4.5
DM (5) 122.0 ± 29.5ab 36.2 ± 2.2ab 262 ± 36ab 1.47 ± 0.12 0.57 ± 0.08a 427±17.1ab
DM+Genta (5) 87.1± 34.1c 24.8 ± 10.1c 295 ± 18a 1.90 ± 0.40ab 0.54 ± 0.24a 374±13.0abc
Values represent mean ± standard deviation.
ap <0.05 vs. Citrate.
bp <0.05 vs. Genta.
cp <0.05 vs. DM.
Table 2 – Renal and oxidative function of the Citrate, Genta, DM and DM+Genta groups – São Paulo, SP, Brazil, 2017.
Groups (n) Urinary flow (ml/min)
U. C. 
(mg/dL) S.C. (mg/dL) Clcr/100 (ml/min)
U.P.
(nM/g of cr U) 
TBARS
(nM/g of cr U)
Citrate (5) 0.012 ± 0.001 82.36 ± 9.46 0.38 ± 0.13 0.76 ± 0.16 1.80 ± 0.94 0.19 ± 0.13
Genta (5) 0.018 ± 0.004 50.84 ± 13.23 a 0.90 ± 0.16 0.26 ± 0.05a 7.68 ± 2.65 1.80 ± 0.98
DM (5) 0.055 ± 0.010ab 21.52 ± 3.84 ab 0.99 ± 0.13a 0.47 ± 0.08ab 5.24 ± 2.56 11.73 ± 2.75ab
DM+Genta (5) 0.040 ± 0.018ab 20.33 ± 14.09ab 1.30 ± 0.52a 0.16 ± 0.06ac 10.38 ± 6.07a 21.68 ± 7.00abc
U.C.: urine creatinine; S.C.: serum creatinine; U.P.: urine peroxides; TBARS: thiobarbituric acid reactive substances.
Values represent mean ± standard deviation.
ap<0.05 vs. Citrate.
bp<0.05 vs. Genta.
cp<0.05 vs. DM.
renal function and oxidative stress of the several grouPs
Table 2 shows the renal function, urinary peroxide and 
TBARS data of the various groups. The Citrate group pre-
sented urine flow and creatinine clearance parameters/100 
g considered as normal. The Genta group presents a signifi-
cant reduction in the clearance/100 g, however with urinary 
flow maintenance. The DM group demonstrates reduced 
clearance/100 g when compared to the Citrate and Genta 
groups, with elevated urinary flow. The DM+Genta group 
presented an increase in the urinary flow with an intensi-
fied reduction of renal function with high peroxides and 
TBARS values, indicating significant oxidative damage.
renal hemodynamics
Figure 1A shows an increase in the heart rate of the 
Genta (573.2 ± 36.7) and DM+Genta (580.5 ± 20.4) groups 
when compared to DM (394.0 ± 96.7) and Citrate (410.5 
± 56.7) groups. The mean arterial pressure (figure 1B) 
remained close to citrate values for all groups (Citrate: 105.2 
± 6.8; Genta: 127.0 ± 27.9; DM: 103.6 ± 11.5; DM+Genta: 
94.7 ± 4.8). Figure 1C shows that the Genta (4.00 ± 0.54) 
and DM+Genta (2.30 ± 0.42) groups showed decreased 
renal blood flow in comparison to DM (5.17 ± 2.25) and 
Citrate (7.08 ± 0.69) groups. However, renal vascular resis-
tance (Figure 1D) was elevated in the Genta (32.27 ± 8.39) 
and DM+Genta (42.18 ± 7.29) groups, when compared to 
DM (22.82 ± 10.54) and Citrate (14.90 ± 0.75) groups.
4 www.ee.usp.br/reeusp
Diabetes Mellitus: a risk factor for drug toxicity
Rev Esc Enferm USP · 2018;52:e03347
DISCUSSION
Studies describe Diabetes Mellitus (DM) as a risk fac-
tor for the development of kidney injuries. The continued 
use of nephrotoxic drugs is common in ICUs and becomes 
even more relevant in patients presenting comorbidities 
such as DM(6,15).
DM is a pathology that results in chronic hyperglyce-
mia, as it triggers metabolic disorders due to defects in the 
synthesis and/or secretion of insulin or its action in tissues. 
This is an important pathology on the world scenario due 
to its morbidity and mortality rates, as well as its increasing 
incidence and prevalence rates(16).
In this study it was possible to verify the triad of polyuria, 
polydipsia and polyphagia, in addition to increased capillary 
glycemia (hyperglycemia) in animals chemically induced to 
develop DM. This finding confirms that the model stan-
dardization was successful(7,14).
One of the pathophysiological characteristics of the 
chronic hyperglycemia condition is the development of 
renal hypertrophy resulting from intense glomerular hyper-
filtration, which leads to the thickening of the glomeru-
lar basement membrane and expansion of the mesangial 
matrix(17). As precipitating mechanisms, some studies 
point out an increase in the polyol pathway, non-enzy-
matic glycosylation, with the production of advanced gly-
cation end-products (AGEs) and oxidative stress result-
ing in increased free radicals and altered kinase C protein 
to justify vascular damage caused by high blood glucose 
concentration(18,19).The higher kidney weight/body weight 
ratio found in diabetic animals in this study confirms the 
occurrence of renal hypertrophy.
Renal function in this study was assessed by creati-
nine clearance, which is considered the gold standard 
for measuring the glomerular filtration rate (GFR).The 
Genta group presented reduced creatinine clearance when 
compared to the Citrate group. These findings confirm 
the nephrotoxic potential of this drug, which acts in the 
proximal tubule, being transported into the cells connect-
ing to the lysosomes, where it forms myeloid bodies and 
consequently causes interference in the phosphatidyl ino-
sitol cascade, blocking the hydrolysis of phospholipase C, 
affecting all intracellular signaling and its homeostasis, 
thereby compromising one of the main tubular functions 
which is the absorption of water and sodium to the con-
centration of urine, and thus characterizing renal injury by 
gentamicin(20-21). The DM group additionally presented a 
50% reduction in renal function when compared to citrate. 
Renal injury by DM is clinically and initially character-
ized by an increased glomerular filtration rate (glomerular 
hyperfiltration) and microalbuminuria. However, with pro-
gression of the disease, a reduction in GFR is confirmed 
as demonstrated. This pathophysiological mechanism of 
DM enhances the effect of other injury factors such as 
drug nephrotoxicity. In this study, we found an even more 
pronounced reduction of RF when gentamicin was admin-
istered to diabetic rats. This finding confirms the diabetic 
animal’s vulnerability to other renal exposures. 
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Figure 1 – Heart Rate, Mean Arterial Pressure, Renal Blood Flow and Renal Vascular Resistance. a p<0.05 vs. citrate; bp<0.05 vs. Genta-
micin; cp<0.05 vs. DM. Data are shown as mean ± SD – São Paulo, SP, Brazil, 2017.
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Although the mechanisms by which gentamicin alters 
glomerular filtration are not fully understood, many studies 
have revealed the involvement of renal vasoconstriction 
and direct tubular toxicity as important agents(22-24). In this 
study, assessment of renal blood flow and renal vascular 
resistance demonstrated significant changes in animals 
treated with gentamicin alone and with gentamicin in com-
bination with chronic hyperglycemia, evidencing intense 
hypoperfusion; this differs from what was observed in the 
DM group, in which the values remained similar to those 
of the Citrate group. A study found normal parameters of 
hemodynamics in DM groups which changed when other 
nephrotoxic substances were associated(14). Measuring renal 
hemodynamics contributes to understanding the action 
mechanism of the vasodilator and vasopressin agents 
involved in renal injury models. 
The pathophysiology of oxidative renal injury is 
described based on the exacerbated consumption of 
ATP, which occurs in the case of hypoxia in the renal 
medulla, which in turn induces abnormalities in oxygen 
metabolism such as the generation of ROS with nitrogen 
compounds (peroxide nitrite), oxygen (hydroxyl radical), 
glycation and formation of adenosine and its metabolite 
hypoxanthine(25-26). The present study evaluated oxidative 
stress through measuring urinary peroxides and TBARS. 
The isolated use of gentamicin presented increased yet not 
significant values of oxidative metabolites. On the other 
hand, in the DM groups and especially the DM+Genta 
group, the significant increase of the markers demon-
strated free radicals and oxidizing agents participating in 
the associated model of diabetic nephropathy with drug 
nephropathy. Studies of isolated analyzes have demon-
strated oxidative damage caused by advanced oxidation 
protein products (AOPP) and catalase antioxidant 
enzyme in gentamicin nephrotoxicity models(27),and by 
lipid peroxidation and analysis of thiols in diabetes(26). 
Association of chronic hyperglycemia and treatment with 
the nephrotoxic aminoglycoside gentamicin reveals more 
aggressive oxidative renal lesions, with cellular apoptosis 
which results in a chronic renal injury model, as repro-
duced in this study.
Experimental studies with animals that reproduce 
clinical situations aiming for elucidating individualized 
pathophysiological factors facilitate clinical reasoning 
and help in the identification of patients at risk for drug 
nephropathy by the multiprofessional team, such as those 
induced by gentamicin. 
Considering that in recent years sedentary lifestyles cou-
pled with obesity have triggered an increase in the number 
of individuals with Diabetes Mellitus, and that a lack of 
adherence to chronic hyperglycemia treatment may make 
them more susceptible to side effects of medications such as 
nephrotoxicity(28), this study implemented an animal model 
of diabetes and nephrotoxicity and confirmed that hypergly-
cemia associated with the toxic insult of gentamicin resulted 
in severe acute kidney injury, characterizing DM as a risk 
factor for drug nephropathy.
CONCLUSION
DM animals show signs of diabetic nephropathy with 
reduced RF and elevated lipid peroxidation. Gentamicin 
induced a reduction in RF and increased generation of oxi-
dizing agents, with an elevation in RVR and RBF. Treatment 
with gentamicin in rats with DM induced worsening of RF, 
lipid peroxidation with significant elevation in RVR and 
reduced RBF.
RESUMO
Objetivo: Avaliar o efeito do antibiótico gentamicina em modelo experimental na presença de Diabetes Mellitus por meio da função 
renal e perfil oxidativo. Método: Ratos Wistar, adultos, machos, foram distribuídos nos grupos: Citrato; Gentamicina (Genta), 
(gentamicina 100 mg/kg de peso corporal, 1 vez ao dia, intraperitoneal, i.p., 5 dias); DM (60 mg/kg de STZ, intravenosa, i.v., dose 
única, diluída em tampão citrato) e DM+Genta. Foram avaliados os parâmetros fisiológicos, a função renal (clearance de creatinina), 
a lesão oxidativa (peróxidos e substâncias reativas ao ácido tiobarbitúrico − TBARS urinários) e a hemodinâmica renal.  Resultados: 
O grupo Diabetes Mellitus apresentou hiperglicemia crônica, associada à perda de peso corporal, polifagia, polidipsia e poliúria, além 
de redução da função renal, com aumento na excreção de metabólitos oxidativos. A administração de gentamicina induziu a redução 
do fluxo sanguíneo renal e o aumento da resistência vascular renal em ratos saudáveis. A associação do Diabetes Mellitus com 
gentamicina resultou em redução adicional na função renal e elevação de metabólitos oxidativos, com aumento de resistência vascular 
renal. Conclusão: A existência de Diabetes Mellitus determinou a elevação da nefrotoxicidade da gentamicina e se confirmou como 
fator de risco para nefrotoxicidade de medicamentos.
DESCRITORES
Lesão Renal Aguda; Diabetes Mellitus; Gentamicina; Estresse oxidativo.
RESUMEN
Objetivo: Evaluar el efecto del antibiótico gentamicina en modelo experimental en la presencia de Diabetes Mellitus mediante la 
función renal y el perfil oxidativo. Método: Ratas Wistar, adultas, machos, fueron distribuidas en los grupos: Citrato; Gentamicina 
(Genta), (gentamicina 100 mg/kg de peso corporal, 1 vez al día, intraperitoneal, i.p., 5 días); DM (60 mg/kg de STZ, intravenosa, i.v., 
dosis única, diluida en tampón citrato) y DM+Genta. Fueron evaluados los parámetros fisiológicos, la función renal (aclaramiento de 
creatinina), la lesión oxidativa (peróxidos y sustancias reactivas al ácido tiobarbitúrico – TBARS urinarios) y la hemodinámica renal. 
Resultados: El grupo Diabetes Mellitus presentó hiperglucemia crónica, asociada con pérdida de peso corporal, polifagia, polidipsia 
y poliuria, además de reducción de la función renal, con aumento en la secreción de metabolitos oxidativos. La administración de 
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